Novartis takes Entresto case to U.S. cardiologist meeting

ZURICH (Reuters) - Novartis took its campaign to invigorate sluggish sales of its new heart-failure medicine Entresto to a U.S. cardiologists meeting on Saturday, telling attendees that even clinically stable patients can benefit from the drug.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro